Acceleration of Competition for Individual Ingredients

In the functional food industry, competition to secure differentiated ingredients first has become much more pronounced. University startups are using follow-up government R&D funding as a springboard to expand their clinical evidence, while companies are entering the individually approved ingredient market with new probiotics such as ACE-01 and materials derived from local agricultural products.

This trend stems from the judgment that, rather than simply launching products, companies must turn ingredients themselves into assets in order to avoid price competition. They are thickening their business foundations by elevating regional resources such as Cheonma from North Jeolla into functional ingredients, continuing follow-up approval applications for materials such as heat-treated and cultured dried Bifidobacterium longum HN001, and broadening the scope of indications and rights for women’s health ingredients after completing patent registrations in four countries.

Regulatory Demonstration and the Reorganization of Production Infrastructure

For companies to enter the functional food market more quickly, not only ingredient approval but also the barriers posed by production facilities and regulatory interpretation must be lowered together. Against this backdrop, the Jeonbuk Regulatory-Free Special Zone for Functional Foods has begun field tests on the use of unlisted ingredients in general foods and on shared production models, in an effort to reduce the bottlenecks small and medium-sized companies face at the commercialization stage.

Both in Korea and abroad, attempts to link production hubs and distribution hubs at the same time are also increasing. A Korean company is connecting local plant resources and production infrastructure in Brazil through an agreement to promote a biofactory, while the Jeonnam-Gwangju region is seeking to build a structure that connects everything from R&D to exports in a single line by leveraging the overseas Korean business network. This shows that the functional ingredient industry is no longer moving only within laboratories.

Distribution Expansion and Diversification of Revenue Models

Companies that have confirmed demand are moving quickly beyond online test sales to large offline channels. Lienjk’s expansion of its sales network to 50 offline Costco stores across the United States, and a sleep health brand’s securing of 4 billion won in funding to expand into pharmacies, duty-free shops, and overseas channels, suggest that functional consumer goods are being re-evaluated through the language of investment and distribution.

In particular, biotech companies’ entry into the health functional food sector strongly reflects a survival strategy for R&D-driven firms. To reduce revenue gaps during the long haul of new drug development, they are pursuing products with relatively faster commercialization in parallel. This both accelerates the commercialization of core technologies and serves to pre-verify how the market actually accepts those technologies.

Growing Pressure for Safety Management and Consumer Protection

As the market expands, the burden of oversight is also rising rapidly. Reports of adverse cases related to health functional foods have reached 18,693 cases, and cases of misleading advertising that caused general foods to be mistaken for functional foods totaled 23,324 cases. In addition, distribution cases involving general foods with aloin content ranging from 1,300 to 15,000 mg/kg have also come to light, showing that blind spots outside the regulatory system are turning into real risks.

For this reason, the industry’s next source of competitiveness is likely to be determined more by trust management than by efficacy claims. Companies are strengthening anti-counterfeit measures in cooperation with customs authorities in more than 30 countries, while from the consumer side, guidance on basic rights is becoming increasingly important, such as the right to cancel door-to-door sales purchases within 14 days. As a result, the functional products market is entering a growth phase while at the same time being asked to refine its systems of verification and oversight.